A detailed history of Capital Research Global Investors transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Capital Research Global Investors holds 8,113,137 shares of TMO stock, worth $4.61 Billion. This represents 1.1% of its overall portfolio holdings.

Number of Shares
8,113,137
Previous 7,989,614 1.55%
Holding current value
$4.61 Billion
Previous $4.24 Billion 11.19%
% of portfolio
1.1%
Previous 1.07%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$528.82 - $599.43 $65.3 Million - $74 Million
123,523 Added 1.55%
8,113,137 $4.72 Billion
Q4 2023

Feb 13, 2024

BUY
$431.41 - $532.94 $223 Million - $276 Million
517,137 Added 6.92%
7,989,614 $4.24 Billion
Q3 2023

Nov 13, 2023

BUY
$498.29 - $574.41 $688 Million - $793 Million
1,381,152 Added 22.67%
7,472,477 $3.78 Billion
Q2 2023

Aug 11, 2023

BUY
$508.46 - $591.13 $80.1 Million - $93.1 Million
157,512 Added 2.65%
6,091,325 $3.18 Billion
Q1 2023

May 15, 2023

SELL
$535.0 - $604.82 $655 Million - $741 Million
-1,224,453 Reduced 17.11%
5,933,813 $3.42 Billion
Q4 2022

Feb 14, 2023

SELL
$484.71 - $571.37 $775 Million - $913 Million
-1,598,526 Reduced 18.25%
7,158,266 $3.94 Billion
Q3 2022

Nov 14, 2022

BUY
$507.19 - $604.49 $6.22 Million - $7.41 Million
12,258 Added 0.14%
8,756,792 $4.44 Billion
Q2 2022

Aug 15, 2022

BUY
$500.9 - $612.21 $27.6 Million - $33.7 Million
55,023 Added 0.63%
8,744,534 $4.75 Billion
Q1 2022

May 16, 2022

SELL
$524.0 - $644.92 $401 Million - $493 Million
-764,521 Reduced 8.09%
8,689,511 $5.13 Billion
Q4 2021

Feb 14, 2022

BUY
$569.0 - $667.24 $118 Million - $139 Million
208,075 Added 2.25%
9,454,032 $6.31 Billion
Q3 2021

Nov 15, 2021

BUY
$509.53 - $609.78 $94.5 Million - $113 Million
185,462 Added 2.05%
9,245,957 $5.28 Billion
Q2 2021

Aug 16, 2021

BUY
$441.0 - $508.24 $90.7 Million - $105 Million
205,674 Added 2.32%
9,060,495 $4.57 Billion
Q1 2021

May 14, 2021

SELL
$439.85 - $518.83 $476 Million - $561 Million
-1,081,065 Reduced 10.88%
8,854,821 $4.04 Billion
Q4 2020

Feb 12, 2021

SELL
$435.06 - $527.66 $714 Million - $866 Million
-1,641,495 Reduced 14.18%
9,935,886 $4.63 Billion
Q3 2020

Nov 13, 2020

SELL
$359.77 - $441.52 $30.6 Million - $37.5 Million
-84,968 Reduced 0.73%
11,577,381 $5.11 Billion
Q2 2020

Aug 14, 2020

SELL
$275.2 - $362.34 $34.2 Million - $45 Million
-124,307 Reduced 1.05%
11,662,349 $4.23 Billion
Q1 2020

May 15, 2020

SELL
$255.3 - $340.05 $2.66 Million - $3.54 Million
-10,404 Reduced 0.09%
11,786,656 $3.34 Billion
Q4 2019

Feb 18, 2020

SELL
$271.93 - $328.04 $64.6 Million - $77.9 Million
-237,594 Reduced 1.97%
11,797,060 $3.83 Billion
Q3 2019

Nov 14, 2019

SELL
$268.46 - $305.43 $222 Million - $252 Million
-825,981 Reduced 6.42%
12,034,654 $3.51 Billion
Q2 2019

Aug 14, 2019

SELL
$257.51 - $295.55 $465 Million - $533 Million
-1,804,915 Reduced 12.31%
12,860,635 $3.78 Billion
Q1 2019

May 15, 2019

SELL
$212.17 - $273.72 $268 Million - $346 Million
-1,264,804 Reduced 7.94%
14,665,550 $4.01 Billion
Q4 2018

Feb 14, 2019

BUY
$208.47 - $251.98 $8 Million - $9.67 Million
38,359 Added 0.24%
15,930,354 $3.57 Billion
Q3 2018

Nov 14, 2018

SELL
$205.57 - $244.32 $560 Million - $665 Million
-2,722,861 Reduced 14.63%
15,891,995 $3.88 Billion
Q2 2018

Aug 14, 2018

SELL
$203.14 - $219.53 $44 Million - $47.5 Million
-216,590 Reduced 1.15%
18,614,856 $3.86 Billion
Q1 2018

May 15, 2018

SELL
$192.98 - $224.11 $134 Million - $155 Million
-693,055 Reduced 3.55%
18,831,446 $3.89 Billion
Q4 2017

Feb 14, 2018

BUY
$182.03 - $200.37 $200 Million - $220 Million
1,097,165 Added 5.95%
19,524,501 $3.71 Billion
Q3 2017

Nov 14, 2017

BUY
$171.74 - $194.04 $3.16 Billion - $3.58 Billion
18,427,336
18,427,336 $3.49 Billion

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $223B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.